Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer

被引:40
|
作者
Oba, SM
Wang, YJ
Song, JP
Li, ZY
Kobayashi, K
Tsugane, S
Hamada, GS
Tanaka, M
Sugimura, H
机构
[1] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan
[2] Hosp Santa Cruz, Res Ctr, Nikkei Dis Prevent Ctr, BR-04122000 Sao Paulo, SP, Brazil
[3] Natl Canc Ctr, Res Inst E, Epidemiol & Bioestat Div, Chiba 2778577, Japan
关键词
EphB2; colorectal tumor; loss of heterozygosity; polymorphism; genomic structure;
D O I
10.1016/S0304-3835(00)00716-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EphB2, a member of the Eph receptor protein-tyrosine kinase family, is overexpressed in several human gastrointestinal tumors. Furthermore, the EphB2 gene is localized at 1p35-p36.1, a frequently deleted region in colon and other cancers. So, despite its overexpression in some kind of tumors, we decided to study the possibility of involvement in the EphB2 gene (EPHB2) mutation in colon cancers, because some of the well known tumor suppressor genes (e.g. p53) is overexpressed (really accumulated) in tumors. Fifty colon tumor samples of matched with their respective normal tissues, were studied for mutation of the EPHB2. Analysis of the genomic structure of EphB2 and survey of all 16 exons revealed an infrequent polymorphism (intron 2) and mutation (intron 8). Another polymorphism in exon 6, localized at nucleotide 1359 (A --> G) was found to be rather frequent in Japanese and Chinese subjects, but very rare in Caucasians. Taking advantage of this polymorphism within EPHB2, we surveyed the loss of heterozygosity (LOH) status of this gene in Japanese colorectal tumors. Among the 50 samples analyzed, 24 were informative, and LOH was found in five of the 15 (33.3%) informative rectal cancer cases. Mutation analysis covering all 16 exons in the remaining allele did not reveal any mutations. Thus, EPHB2 is not a classical tumor suppressor gene. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [1] EphB2 is a prognostic factor in colorectal cancer
    Jubb, AN
    Zhong, F
    Bheddah, S
    Grabsch, HI
    Frantz, GD
    Mueller, W
    Kavi, V
    Quirke, P
    Polakis, P
    Koeppen, H
    [J]. JOURNAL OF PATHOLOGY, 2006, 208 : 13A - 13A
  • [2] EphB2 is a prognostic factor in colorectal cancer
    Jubb, AM
    Zhong, F
    Bheddah, S
    Grabsch, HI
    Frantz, GD
    Mueller, W
    Kavi, V
    Quirke, P
    Polakis, P
    Koeppen, H
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5181 - 5187
  • [3] Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression
    Jang, Bo Gun
    Kim, Hye Sung
    Chang, Weon Young
    Bae, Jeong Mo
    Kang, Gyeong Hoon
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (05) : 298 - 306
  • [4] Characterisation of germline EPHB2 variants in familial colorectal cancer
    Zogopoulos, George
    Bacani, Julinor
    Montpetit, Alexandre
    Chad, Lauren
    Greenwood, Celia
    Cotterchio, Michelle
    Zanke, Brent
    Hudson, Thomas
    Gallinger, Steven
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [5] Germline EPHB2 Receptor Variants in Familial Colorectal Cancer
    Zogopoulos, George
    Jorgensen, Claus
    Bacani, Julinor
    Montpetit, Alexandre
    Lepage, Pierre
    Ferretti, Vincent
    Chad, Lauren
    Selvarajah, Subani
    Zanke, Brent
    Hudson, Thomas J.
    Pawson, Tony
    Gallinger, Steven
    [J]. PLOS ONE, 2008, 3 (08):
  • [6] The Roles of EphB2 in Cancer
    Liu, Wei
    Yu, Chengpeng
    Li, Jianfeng
    Fang, Jiwei
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [7] EphB2: a signature of colorectal cancer stem cells to predict relapse
    Zhang, Xiaoxue
    [J]. PROTEIN & CELL, 2011, 2 (05) : 347 - 348
  • [8] EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis
    Kokko, Antti
    Laiho, Paeivi
    Lehtonen, Rainer
    Korja, Sanna
    Carvajal-Carmona, Luis G.
    Jaervinen, Heikki
    Mecklin, Jukka-Pekka
    Eng, Charis
    Schleutker, Johanna
    tomlinson, Ian P. M.
    Vahteristo, Pia
    Aaltonen, Lauri A.
    [J]. BMC CANCER, 2006, 6 (1)
  • [9] c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer
    Fu, Tao
    Li, Peng
    Wang, Hanzhi
    He, Yujun
    Luo, Donglin
    Zhang, Anping
    Tong, Weidong
    Zhang, Lianyang
    Liu, Baohua
    Hu, Chuanmin
    [J]. JOURNAL OF PATHOLOGY, 2009, 219 (01): : 103 - 113
  • [10] EphB2: a signature of colorectal cancer stem cells to predict relapse
    Xiaoxue Zhang
    [J]. Protein & Cell., 2011, 2 (05) - 348